Can non-narcotic painkillers curb fentanyl overuse - KBR
| 244460 Stock | KRW 6,390 1,220 23.60% |
About 55% of OLIPASS's investors are presently thinking to get in. The analysis of current outlook of investing in OLIPASS suggests that some traders are interested regarding OLIPASS's prospects. The current market sentiment, together with OLIPASS's historical and current headlines, can help investors time the market. In addition, many technical investors use OLIPASS stock news signals to limit their universe of possible portfolio assets.
OLIPASS |
Can non-narcotic painkillers curb fentanyl overuse KBR
Read at news.google.com
 |
OLIPASS Fundamental Analysis
We analyze OLIPASS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OLIPASS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OLIPASS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
OLIPASS is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
OLIPASS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OLIPASS stock to make a market-neutral strategy. Peer analysis of OLIPASS could also be used in its relative valuation, which is a method of valuing OLIPASS by comparing valuation metrics with similar companies.
Peers
OLIPASS Related Equities
| 005300 | Lotte Chilsung | 2.61 | ||||
| 090370 | MetaLabs | 0.37 | ||||
| 120240 | Daejung Chemicals | 0.16 | ||||
| 003230 | Samyang Foods | 0.38 | ||||
| 077360 | Duksan Hi | 2.01 |
Complementary Tools for OLIPASS Stock analysis
When running OLIPASS's price analysis, check to measure OLIPASS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OLIPASS is operating at the current time. Most of OLIPASS's value examination focuses on studying past and present price action to predict the probability of OLIPASS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OLIPASS's price. Additionally, you may evaluate how the addition of OLIPASS to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |